10X GENOMICS, INC. [●] Shares of Class A Common Stock, par value $0.00001 per share Underwriting Agreement10x Genomics, Inc. • September 3rd, 2019 • Laboratory analytical instruments • New York
10x Genomics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom J.P. Morgan Securities LLC (“JPM”), Goldman Sachs & Co. LLC (“Goldman”) and BofA Securities, Inc. (“BAML”) are acting as representatives (the “Representatives”), an aggregate of [●] shares of Class A common stock, par value $0.00001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [●] shares of Class A common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Class A common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
10X GENOMICS, INC. FORM OF INDEMNIFICATION AGREEMENTIndemnification Agreement • September 3rd, 2019 • 10x Genomics, Inc. • Laboratory analytical instruments • Delaware
This Indemnification Agreement is dated as of _________, 20__ (this “Agreement”) and is between 10x Genomics, Inc., a Delaware corporation (the “Company”), and [name of director/officer] (“Indemnitee”).
